Compared to before L-GSH supplementation, the untreated (control) category had a significant 3-fold decrease in the levels of IL-10 from the in vitro granulomas generated from T2DM subjects at 3-months post- L-GSH supplementation (Figure 7B). The gene discussed is IL10; the disease is type 2 diabetes mellitus.